CI Investments Inc’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
6,066
+3,736
+160% +$774K ﹤0.01% 533
2026
Q1
$523K Sell
2,330
-108
-4% -$26.9K ﹤0.01% 477
2025
Q4
$587K Sell
2,438
-1,580
-39% -$404K ﹤0.01% 481
2025
Q3
$1.1M Sell
4,018
-902
-18% -$246K ﹤0.01% 423
2025
Q2
$1.27M Sell
4,920
-79
-2% -$18.8K ﹤0.01% 402
2025
Q1
$1.12M Sell
4,999
-1,206
-19% -$282K ﹤0.01% 413
2024
Q4
$1.42M Buy
6,205
+803
+15% +$193K 0.01% 379
2024
Q3
$1.32M Buy
5,402
+36
+0.7% +$8.04K 0.01% 384
2024
Q2
$1.03M Sell
5,366
-316
-6% -$64.1K ﹤0.01% 390
2024
Q1
$1.13M Buy
5,682
+2,004
+54% +$367K ﹤0.01% 380
2023
Q4
$633K Buy
3,678
+101
+3% +$15.5K ﹤0.01% 413
2023
Q3
$529K Sell
3,577
-381
-10% -$68.9K ﹤0.01% 423
2023
Q2
$865K Buy
3,958
+1,595
+67% +$355K ﹤0.01% 385
2023
Q1
$517K Buy
2,363
+1,025
+77% +$222K ﹤0.01% 429
2022
Q4
$278K Buy
1,338
+229
+21% +$50.3K ﹤0.01% 539
2022
Q3
$242K Buy
1,109
+155
+16% +$35.3K ﹤0.01% 556
2022
Q2
$200K Sell
954
-792
-45% -$169K ﹤0.01% 604
2022
Q1
$423K Sell
1,746
-331
-16% -$80.1K ﹤0.01% 562
2021
Q4
$541K Sell
2,077
-2,098
-50% -$544K ﹤0.01% 562
2021
Q3
$1.1M Buy
4,175
+2,740
+191% +$749K ﹤0.01% 448
2021
Q2
$354K Buy
1,435
+559
+64% +$118K ﹤0.01% 661
2021
Q1
$170K Sell
876
-343
-28% -$68.8K ﹤0.01% 693
2020
Q4
$259K Buy
1,219
+622
+104% +$124K ﹤0.01% 624
2020
Q3
$102K Buy
+597
New +$110K ﹤0.01% 659

Other funds holding RMD

CI Investments Inc's RMD Position: Q2 2026 in Review

CI Investments Inc increased its ResMed (RMD) stake by 160% in Q2 2026, buying an estimated $774K and bringing the position to 6,066 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #533.

CI Investments Inc first reported a position in RMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.42M in Q4 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • CI Investments Inc held 6,066 shares of ResMed worth $1.18M as of Q2 2026.
  • CI Investments Inc bought 3,736 ResMed shares in Q2 2026, an estimated $774K.
  • ResMed made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #533 holding.
  • CI Investments Inc first reported a position in ResMed in Q3 2020 and has held it in 24 quarters since.
  • CI Investments Inc's ResMed position peaked at $1.42M in Q4 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.